• HOME
  • Pipeline
  • Clinical Focus
  • Technology
  • Team
  • News
  • About
  • HOME
  • Pipeline
  • Clinical Focus
  • Technology
  • Team
  • News
  • About
  • canstockphoto6244971

    Febrile neutropenia is a common,
    life-threatening
    complication of chemotherapy

  • canstockphoto62820667

    Gut barrier Injury and Neutrophil
    depletion puts patients at risk for
    bacteremia and sepsis

  • canstockphoto7427952

    AKTHELIA'S DRUG CANDIDATE KNOCKS OUT
    BACTERAEMIA BY STRENGTHENING
    INNATE GUT BARRIER DEFENSES

  • N1WT6iuIb

    eliminating the need for prophylactiC antibiotics

  • V1fz3suL-

    reducing risk of serious adverse events,
    antimicrobial resistance and
    microbiome dysbiosis

  • HOME
  • News
  • Antimicrobial Peptides 2019, Gordon Research Conference

Antimicrobial Peptides 2019, Gordon Research Conference

Akthelia strongly represented at this scientific conference

January 28, 2019

The focus of the 2019 Gordon Conference on Antimicrobial Peptides is utilizing our knowledge of mechanisms of AMP action, and mining species diversity to advance application to global infection challenges, including the threat of antimicrobial resistance, and sharing experience of translating fundamental research to commercial development and clinical practice.

Akthelia is strongly represented at this conference:

  • Birgitta Agerberth, co-founder, has a með Keynote talk titled ""From the Discovery of the Cathelicidin LL-37 to Host-Directed Therapy Fighting Infections"
  • Guðmundur Hrafn Guðmundsson, co-founder, is a discussion leader in a session on "Exploiting Mechanistic Knowledge to Utilize Immunomodulatory Activities"
  • Rubhana Raqib from the International Centre for Diarrhoeal Disease Research, a long-time collaborator of Akthelia's founders has a presentation on "Induction of Antimicrobial Host Defense Peptides as a Therapeutic Strategy Against Tuberculosis"
  • And finally, Iwona T. Myszor from the Biomedical Center at the University of Iceland has a poster presentation showing how Akthelia's compounds enhance antimicrobial defense and maintain airway epithelial barrier integrity

More information about the conference here.

AKTHELIA

  • Grandagarði 16, 101 Reykjavik
  • akthelia@akthelia.is
  • 610502-6440
  • Twitter
© 2023 AKTHELIA